Data / Form D filings / PHASERX, INC.
PHASERX, INC.: Form D filings
PHASERX, INC., a biotechnology company in Seattle, WA, filed 10 Form D notices with the SEC between 2009 and 2016. The latest, on June 9, 2016, reports an offering of $420,000 with nothing sold yet to 1 investor.
Find out what PHASERX, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 410 WEST HARRISON STREET, SUITE 300, Seattle, WA, 98119
- Phone
- (206) 805-6300
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1429386
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 9, 2016 | New notice | $420,000 | $0 | $420,000 | 1 | Jun 7, 2016 | sec.gov |
| Dec 29, 2015 | New notice | $4,000,000 | $4,000,000 | $0 | 17 | Dec 21, 2015 | sec.gov |
| Dec 17, 2013 | New notice | $1,540,015 | $0 | $1,540,015 | 4 | Dec 4, 2013 | sec.gov |
| Oct 2, 2013 | New notice | $1,400,014 | $1,400,014 | $0 | 2 | Sep 19, 2013 | sec.gov |
| Jul 11, 2013 | New notice | $1,400,014 | $500,005 | $900,009 | 1 | Jun 28, 2013 | sec.gov |
| Dec 21, 2012 | New notice | $3,000,031 | $1,500,016 | $1,500,015 | 6 | Dec 10, 2012 | sec.gov |
| Jul 6, 2012 | New notice | $1,600,016 | $1,600,016 | $0 | 2 | Jul 2, 2012 | sec.gov |
| Feb 14, 2012 | New notice | $4,650,037 | $3,600,037 | $1,050,000 | 5 | Feb 1, 2012 | sec.gov |
| Feb 22, 2010 | Amendment | $1,216,583 | $1,216,583 | $0 | 14 | Aug 17, 2009 | sec.gov |
| Aug 26, 2009 | New notice | $302,654 | $302,654 | $0 | 10 | Aug 17, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| PAUL W. JOHNSON | Executive Officer, Director | |
| Michael W. Houston | Executive Officer | |
| Shing-Yin (Helen) W. Tsui | Executive Officer | |
| JOHN W. SCHMIDT | Director | |
| ROBERT W. OVERELL | Executive Officer, Director, Promoter | |
| BRIAN W. ATWOOD | Director | |
| Richard W. Ulevitch | Director | |
| Michelle W. Griffin | Director | |
| STEVEN W. GILLIS | Director |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Jun 6, 2016 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PHASERX, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.